AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Implantable Analyte Sensor

Technology Benefits

Membrane may be fabricated with precisely defined pore size May be fabricated using standard microfabrication techniquesSensor membrane can be fabricated to give a glucose diffusion test result of at least 1 mg/dl in 330 minutes and an albumin diffusion test result of at most 0.1 g/dl in 420 minutes

Technology Application

Implantable glucose sensor

Detailed Technology Description

None

Supplementary Information

Patent Number: US6405066B1
Application Number: US2000528277A
Inventor: Essenpreis, Matthias | Desai, Tejal A. | Ferrari, Mauro | Hansford, Derek J.
Priority Date: 17 Mar 2000
Priority Number: US6405066B1
Application Date: 17 Mar 2000
Publication Date: 11 Jun 2002
IPC Current: G01N0033483 | A61B000500 | A61B0005145 | A61B00051473 | C12M000134 | C12Q000100 | G01N0027327 | G01N002740 | G01N0027416 | G01N003366 | G01N003368
US Class: 600347 | 204415 | 600345 | 600377 | 204403
Assignee Applicant: The Regents of the University of California | Roche Diagnostics Corporationdianapolis
Title: Implantable analyte sensor
Usefulness: Implantable analyte sensor
Summary: Used in vivo , preferably subcutaneously in mammals, e.g. humans, dogs, or mice.
Novelty: Glucose sensor used subcutaneously in mammals, e.g. humans, includes membrane comprising elemental silicon and has specified glucose and albumin diffusion test results

Industry

Electronics

Sub Group

Circuit Design

Application No.

6405066

Others

Tech ID/UC Case

17009/2001-030-0

Related Cases

2001-030-0

Country/Region

USA

For more information, please click Here